How Can We Help You?

Tag Archives: Global

 HomeBizzell US  Blog  Global
Categories Insights Tags Behavioral Health, CEO Insights, COVID-19, Ebola, Global, Health, Mental Health

Dr. Bizzell Speaks About the First FDA-Approved Treatment for Ebola

Dr. Bizzell Speaks About the First FDA-Approved Treatment for Ebola

Dr. Anton C. Bizzell shares his insights in the Verywell Health article, “Regeneron Earns First-Ever FDA Approval For Ebola Treatment,” about the U.S. Food and Drug Administration (FDA) approval of Inmazeb, an antibody cocktail designed to treat the Ebola virus. A mixture of three monoclonal antibodies administered via injection is the first FDA-approved treatment for the virus. The drug is manufactured by Regeneron, the same company behind the antibody cocktail aimed at treating COVID-19. The Bizzell Group (Bizzell) has been on the ground fighting the Ebola virus in the Democratic Republic of Congo. “The approval of Inmazeb is not only a big deal, it is the approach to prevent a future Ebola pandemic worldwide,” Dr. Bizzell tells Verywell.

READ MORE: Regeneron Earns First-Ever FDA Approval For Ebola Treatment

Categories Insights Tags Behavioral Health, CEO Insights, COVID-19, Ebola, Global, Health, Mental Health

Lessons for COVID-19 Recovery From the Ebola Epidemic

Lessons for COVID-19 Recovery From the Ebola Epidemic

In a recent Psychology Today article, Dr. Anton C. Bizzell highlights some of the lessons The Bizzell Group (Bizzell) learned during the most recent Ebola virus epidemic. Bizzell partnered with local, national, and international groups to improve health outcomes and mental health consequences in the Democratic Republic of Congo. These lessons can help address the global mental health crisis already emerging due to COVID-19.

“We cannot focus solely on the transmission of COVID-19,” Dr. Bizzell writes. “We must formulate an innovative and sustainable response that addresses the global mental health crisis already emerging.”

READ MORE: Lessons for COVID-19 Recovery From the Ebola Epidemic

Categories Global Development, Tobacco Tags Centers for Disease Control and Prevention (CDC), Communications & Outreach, Conference Services, Global, Global Development, Health, National Cancer Institute (NCI), Thought Leadership

17th World Conference on Tobacco or Health

17th World Conference on Tobacco or Health

Project Director Jenny Twesten traveled to Cape Town, South Africa to represent the National Cancer Institute’s Tobacco Control Research Branch at WCTOH held March 6-9, 2018. This international conference drew participants from around the world, with a particularly strong presence from those across Africa, an area where prevalence of cigarette smoking is on the rise and expected to continue to do so without strong tobacco control interventions. The Bizzell Group (Bizzell) supported meeting logistics for a pre-conference workshop entitled “Research to Inform the Development and Implementation of Tobacco Control Policies and Intervention” that was attended by at least 53 people from 23 different countries.

Bizzell also coordinated the NCI presence in the exhibit hall in collaboration with the Centers for Disease Control and Prevention, which nearly ran out of materials within 4 hours of the exhibit hall opening. In addition to attending sessions on electronic nicotine delivery systems (ENDS), economic and social costs of tobacco among women, tools for monitoring tobacco use, and ending the tobacco epidemic, Jenny presented on the Africa literature review that she and Katie Cleffi have been working on with NCI and met with various organizations and experts to discuss collaboration opportunities with NCI. The abstract presented has been published in a special supplement of Tobacco Induced Diseases. She will be presenting along with the other NCI delegates at an upcoming seminar on April 17 hosted by the NCI Center for Global Health to share insights from their WCTOH attendance.

1 2
Copyright © 2024 Bizzell US All rights reserved.
Bizzell US